ATXS icon

Astria Therapeutics
ATXS

Overview Fund Trends Analyst Outlook Journalist POV

33 hedge funds and large institutions have $52.8M invested in Astria Therapeutics in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

35% less capital invested

Capital invested by funds: $81.4M → $52.8M (-$28.7M)

Holders
33
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$752K
2
+$588K
3
+$202K
4
RPAM
Rhenman & Partners Asset Management
Sweden
+$196K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$76.5K

Top Sellers

1
-$357K
2
-$217K
3
-$205K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$93.7K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$61.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$13K
27
$9K
28
$8K
29
$7K
30
$3K
31
$3K
32
$1K
33
$187
34
–
35
–
36
–
37
–
38
–
39
–
1
2